**Author details**

Agustina Bongioanni† , Maria Soledad Bueno† , Belén Alejandra Mezzano† , Marcela Raquel Longhi and Claudia Garnero\* Department of Pharmaceutical Sciences, Faculty of Chemical Sciences National University of Córdoba, Unit for Research and Development in Pharmaceutical Technology, (UNITEFA) CONICET, Córdoba, Argentina

\*Address all correspondence to: cgarnero@unc.edu.ar

† These authors contributed equally to this work.

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Pharmaceutical Crystals: Development, Optimization, Characterization and Biopharmaceutical… DOI: http://dx.doi.org/10.5772/intechopen.105386*

## **References**

[1] Couillaud BM, Espeau P, Mignet N, Corvis Y. State of the art of pharmaceutical solid forms: From crystal property issues to nanocrystals formulation. ChemMedChem. 2019;**14**:8. DOI: 10.1002/cmdc.201800612

[2] Lajoinie A, Henin E, Kassai B, Terry D. Solid oral forms availabilityin children: A cost saving investigation. British Journal of Clinical Pharmacology. 2014;**78**:1080-1089. DOI: 10.1111/ bcp.12442

[3] Homayun B, Lin X, Choi HJ. Challenges and recent Progress in Oral drug delivery Systems for Biopharmaceuticals. Pharmaceutics. 2019;**11**(3):129. DOI: 10.3390/ pharmaceutics11030129

[4] Lee AY, Erdemir D, Myerson MS. Crystal polymorphism in chemical process development. Annual Review of Chemical and Biomolecular Engineering. 2011;**2**:259-280. DOI: 10.1146/ annurev-chembioeng-061010-114224

[5] Abe H, Koyama Y, Shimono S, Kishimura H, Matsuishi K. High-pressure crystal polymorphs and multiple pathways in 1-hexyl-3-methylimidazolium perfluorobutanesulfonate ionic liquid. Chemical Physics. 2022;**557**:111479. DOI: 10.1016/j.chemphys.2022.111479

[6] Brittain HG, editor. Polymorphism in pharmaceutical solids. In: Center for Pharmaceutical Physics. Milford. Second ed. New Jersey, USA: Informa Healthcare; 2009

[7] Li T, Mattei A. Pharmaceutical Crystals. Science and Engineering: Wiley; 2019

[8] Shi Q, Chen H, Wang Y, Xu J, Liu Z, Zhang C. Recent advances in drug polymorphs: Aspects of pharmaceutical properties and selective crystallization. International Journal of Pharmaceutics. 2022;**611**:121320. DOI: 10.1016/j. ijpharm.2021.121320

[9] Morissette SL, Soukasene S, Levinson D, Cima MJ, Almarsson O. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proceeding of the National Academic of Science. 2003;**100**(5):2180-2184. DOI: 10.1073/pnas.0437744100

[10] Song S, Wang L, Yao C, Wang Z, Xie G, Tao X. Crystallization of sulfathiazole in gel: Polymorph selectivity and cross-nucleation. Crystal Growth & Design. 2020;**20**(1):9-16. DOI: 10.1021/acs.cgd.9b00990

[11] Katzhendler I, Azoury R, Friedman M. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. Journal of Controlled Release. 1998;**54**(1):69-85. DOI: 10.1016/S0168-3659(98)00002-9

[12] Cruz PC, Rocha FA, Ferreira AM. Application of selective crystallization methods to isolate the metastable polymorphs of paracetamol: A review. Organic Process Research & Development. 2019;**23**(12):2592-2607. DOI: 10.1021/acs.oprd.9b00322

[13] Zhang J, Liu Z, Wu H, Cai T. Effect of polymeric excipients on nucleation and crystal growth kinetics of amorphous fluconazole. Biomaterials Science. 2021;**9**:4308-4316. DOI: 10.1039/ D1BM00104C

[14] Berry DJ, Steed JW. Pharmaceutical cocrystals, salts and multicomponent

systems; intermolecular interactions and property based design. Advanced Drug Delivery Reviews. 2017;**117**:3-24. DOI: 10.1016/j.addr.2017.03.003

[15] Kendall T, Stratford S, Patterson AR, Lunt RA, Cruickshank D, Bonnaud T, et al. An industrial perspective on co-crystals: Screening, identification and development of the less utilised solid form in drug discovery and development. Progress in Medicinal Chemistry. 2021;**60**:345-442. DOI: 10.1016/bs.pmch.2021.05.001

[16] Gao L, Zhang XR. Pharmaceutical salt hydrates of vortioxetine with maleic acid and fumaric acid: Crystal structures, characterisation and solubility performance. Journal of Molecular Structure. 2022;**1250**(2):131847. DOI: 10.1016/j.molstruc.2021.131847

[17] Gong W, Mondal PK, Ahmadi S, Wu Y, Rohani S. Cocrystals, salts, and salt-solvates of olanzapine; selection of coformers and improved solubility. International Journal of Pharmaceutics. 2021;**608**:121063. DOI: 10.1016/j. ijpharm.2021.121063

[18] Wang Y, Wang L, Zhang F, Wang N, Gao Y, Xiao Y, et al. Structure analysis and insight into hydrogen bond and van der waals interactions of etoricoxib cocrystals and cocrystal solvate. Journal of Molecular Structure. 2022;**1258**:132665. DOI: 10.1016/j. molstruc.2022.132665

[19] Zhang Y, Li Y, Chang L, Liu L, Feng Y, Wu L, et al. Improving hygroscopic stability of palmatine chloride by forming a pharmaceutical salt cocrystal of palmatine chloride-gallic acid with neutral molecule. Journal of Drug Delivery Science and Technology. 2021;**66**:102839. DOI: 10.1016/j.jddst.2021.102839

[20] Yang D, Wang H, Liu Q, Yuan P, Chen T, Zhang L, et al. Structural

landscape on a series of rhein: Berberine cocrystal salt solvates: The formation, dissolution elucidation from experimental and theoretical investigations. Chinese Chemical Letters. 2021;**33**:3207-3211. DOI: 10.1016/j.cclet.2021.10.012

[21] Guerain M, Guinet Y, Correia NT, Paccou L, Danède F, Hédoux A. Polymorphism and stability of ibuprofen/nicotinamide cocrystal: The effect of the crystalline synthesis method. International Journal of Pharmaceutics. 2020;**584**:119454. DOI: 10.1016/j.ijpharm.2020.119454

[22] Braun DE, Griesser UJ. Stoichoimetric and nonstoichiometric hydrates of brucine. Crystal Growth & Design. 2016;**16**(10):6111-6121. DOI: 10.1021/acs.cgd.6b01231

[23] Clarke HDM. Crystal Engineering of Multi-Component Crystal Forms: The Opportunities and Challenges in Design. Graduates These and Dissertations. Tampa, Florida, USA: University of South Florida, Scholar Commons; 2012. Available from: https://digitalcommons. usf.edu/etd/4013/

[24] Sun Y. Improved solubility of gefitinib achieved by the wateracetone solvate. Journal of the Indian Chemical Society. 2022;**99**(1):100260. DOI: 10.1016/j.jics.2021.100260

[25] Costa RN, Reviglio AL, Siedler S, Cardoso SG, Linck YG, Monti GA, et al. New multicomponent forms of the antiretroviral Nevirapine with improved dissolution performance. Crystal Growth & Design. 2020;**20**(2):688-698. DOI: 10.1021/acs.cgd.9b01129

[26] Delori A, Friscic T, Jones W. The role of mechaochemistry and supramolecular desing in the development of pharmaceutical materials. CrystEngComm. 2012;**14**(7):2350-2361. DOI: 10.1039/C2CE06582G

*Pharmaceutical Crystals: Development, Optimization, Characterization and Biopharmaceutical… DOI: http://dx.doi.org/10.5772/intechopen.105386*

[27] Erdemir D, Lee A, Myerson A. Crystal nucleation. In: Myerson A, Erdemir D, Lee A, editors. Handbook of Industrial. Crystallization Cambridge: Cambridge University Press; 2019. pp. 76-114. DOI: 10.1017/9781139026949.003

[28] Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Advanced Drug Delivery Reviews. 2007;**59**(7):617-630. DOI: 10.1016/j. addr.2007.05.011

[29] Aaltonen J, Allesø M, Mirza S, Koradia V, Gordon KC, Rantanen J. Solid form screening – A review. European Journal of Pharmaceutics and Biopharmaceutics. 2009;**71**:23-37. DOI: 10.1016/j.ejpb.2008.07.014

[30] Bernstein J, editor. Polymorphism in Molecular Crystals. Oxford: Clarendon Press; 2002

[31] Heinz A, Strachan CJ, Keith C, Gordon KC, Rades T. Analysis of solidstate transformations of pharmaceutical compounds using vibrational spectroscopy. Journal of Pharmacy and Pharmacology. 2009;**61**:971-988. DOI: 10.1211/jpp/61.08.0001

[32] Law D, Zhou D. Solid-state characterization and techniques. In: Qiu Y, Zhang GGZ, Mantri RV, Chen Y, Yu L, editors. Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice. 2nd ed. Amsterdam: Academic Press; 2017. pp. 59-84. DOI: 10.1016/ B978-0-12-802447-8.00003-0

[33] Nanjwade VK, Manvi FV, Shamrez AM, Nanjwade BK, Maste MM. New trends in the Co-crystallization of active pharmaceutical ingredients. Journal of Applied Pharmaceutical Science. 2011;**1**(8):1-5

[34] Chiu MH, Prenner EJ. Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. Journal of Pharmacy and Bioallied Sciences. 2011;**3**(1):39-60. DOI: 10.4103/0975-7406.76463

[35] Lu E, Rodríguez-Hornedo N, Suryanarayanan RA. Rapid thermal method for cocrystal screening. CrystEngComm. 2008;**10**:665-668. DOI: 10.1039/B801713C

[36] Qiao Y, Qiao R, He Y, Shi C, Liu Y, Hao H, et al. Instrumental analytical techniques for the characterization of crystals in pharmaceutics and foods. Crystal Growth & Design. 2017;**17**(11):6138-6148. DOI: 10.1021/acs. cgd.7b00759

[37] Kojnojová T, Markovičová L, Nový F. Application of thermal gravimetric analysis and comparison of polyethylene films before and after exposure in various chemical solutions. Conference Series: Materials Science and Engineering. 2021;**1178**:012029. DOI: 10.1088/1757-899X/1178/1/012029

[38] Karki S, Fabian L, Friscic T, Jones W. Powder X-ray diffraction as an emerging method to structurally characterize organic solids. Organic Letters. 2007;**9**:3133-3136. DOI: 10.1021/ ol071329t

[39] Chieng N, Hubert M, Saville D, Rades T, Aaltonen J. Formation kinetics and stability of carbamazepinenicotinamide Cocrystals prepared by mechanical activation. Crystal Growth & Design. 2009;**9**:2377-2386. DOI: /10.1021/ cg801253f

[40] Bond AD. Single-crystal X-ray diffraction. In: Müllertz A, Perrie Y, Rades T, editors. Analytical Techniques in the Pharmaceutical Sciences. New

York: Springer; 2016. pp. 315-337. DOI: 10.1007/978-1-4939-4029-5\_9

[41] Altomare A, Coucci C, Gatta GD, Moliterni A, Rizzi R. Methods of crystallography: Powder X-ray diffraction. European Mineralogical Union Notes in Mineralogy. 2017;**19**(2):79-138. DOI: 10.1180/ EMU-notes.19.3

[42] Song Y, Cong Y, Wang B, Zhang N. Applications of Fourier transform infrared spectroscopy to pharmaceutical preparations. Expert Opinion on Drug Delivery. 2020;**17**(4):551-571. DOI: 10.1080/17425247.2020.1737671

[43] Paradowska K, Wawer I. Solidstate NMR in the analysis of drugs and naturally occurring materials. Journal of Pharmaceutical and Biomedical Analysis. 2014;**93**:27-42. DOI: 10.1016/j. jpba.2013.09.032

[44] Geppi M, Mollica G, Borsacchi S, Veracini CA. Solid-state NMR studies of pharmaceutical systems. Applied Spectroscopy Reviews. 2008;**43**(3):202- 302. DOI: 10.1080/05704920801944338

[45] Carlton RA. Pharmaceutical Microscopy. New York: Springer; 2011. DOI: 10.1007/978-1-4419-8831-7

[46] Huang LF, Tong WQ. Impact of solid state properties on developability assessment of drug candidates. Advanced Drug Delivery Reviews. 2004;**56**(3):321- 334. DOI: 10.1016/j.addr.2003.10.007

[47] Garnero C, Chattah AK, Longhi M. Supramolecular complexes of maltodextrin and furosemide polymorphs: A new approach for delivery systems. Carbohydrate Polymers. 2013;**94**:292-300. DOI: 10.1016/j. carbpol.2013.01.055

[48] Chierentin L, Garnero C, Chattah AK, Delvadia P, Karnes T, Longhi MR, et al. Influence of β-cyclodextrin on the properties of Norfloxacin form a. AAPS PharmSciTech. 2015;**16**(3):683-691. DOI: 10.1208/s12249-014-0259-8

[49] Garnero C, Chattah AK, Aloisio C, Fabietti L, Longhi M. Improving the stability and the pharmaceutical properties of Norfloxacin form C through binary complexes with β-Cyclodextrin. AAPS PharmSciTech. 2018;**19**(5):2255- 2263. DOI: 10.1208/s12249-018-1033-0

[50] Bueno MS, Chierentin L, Bongioanni A, Nunes Salgado HR, Longhi MR, Garnero C. β-Cyclodextrin complexation as an approach to enhance the biopharmaceutical properties of Norfloxacin B hydrate. Carbohydrate Research. 2019;**485**:107818. DOI: 10.1016/j.carres.2019.107818

[51] Chattah AK, Pfund LY, Zoppi A, Longhi MR, Garnero C. Toward novel antiparasitic formulations: Complexes of Albendazole desmotropes and β-cyclodextrin. Carbohydrate Polymers. 2017;**164**:379-385. DOI: 10.1016/j. carbpol.2017.01.098

[52] Bueno MS, Miñambres GG, Bongioanni A, Chattah AK, Aiassa V, Longhi MR, et al. Exploring solid forms of oxytetracycline hydrochloride. International Journal of Pharmaceutics. 2020;**585**:119496. DOI: 10.1016/j. ijpharm.2020.119496

[53] Aguiar AJ, Krc J, Kinkel AW, Samyn JC. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. Journal of Pharmaceutical Sciences. 1967;**56**:847- 853. DOI: 10.1002/jps.2600560712

[54] Otsuka M, Matsumoto T, Kaneniwa N. Effects of the mechanical *Pharmaceutical Crystals: Development, Optimization, Characterization and Biopharmaceutical… DOI: http://dx.doi.org/10.5772/intechopen.105386*

energy of multi-tableting compression on the polymorphic transformations of chlorpropamide. Journal of Pharmacy and Pharmacology. 1989;**41**(10):665-669. DOI: 10.1111/j.2042-7158.1989.tb06337.x

[55] Ueda H, Nambu N, Nagai T. Dissolution behavior of chlorpropamide polymorphs. Chemical and Pharmaceutical Bulletin. 1984;**32**: 244-250. DOI: 10.1248/cpb.32.244

[56] Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. International Journal of Pharmaceutics. 2000;**193**:137-146. DOI: 10.1016/ s0378-5173(99)00315-4

[57] Yang W, Johnston KP, Williams RO III. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. European Journal of Pharmaceutics and Biopharmaceutics. 2010;**75**:33-41. DOI: 10.1016/j. ejpb.2010.01.011

[58] Healy AM, Worku ZA, Kumar D, Madi AM. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals. Advanced Drug Delivery Reviews. 2017;**117**:25-46. DOI: 10.1016/j.addr.2017.03.002

[59] Qiao N, Wang K, Schlindwein W, Davies A, Li M. In situ monitoring of carbamazepine–nicotinamide cocrystal intrinsic dissolution behaviour. European Journal of Pharmaceutics and Biopharmaceutics. 2013;**83**(3):415-426. DOI: 10.1016/j.ejpb.2012.10.005

[60] Jaswanth Gowda BH, Nechipadappu SK, Shankar SJ, Chavali M, Karthika P, Ahmed MG, et al. Pharmaceutical cocrystals of Efavirenz: Towards the improvement of solubility, dissolution rate and stability. Materials

Today: Proceedings. 2022;**51**(1):394-402. DOI: 10.1016/j.matpr.2021.05.535

[61] Bhattacharya B, Mondal A, Soni SR, Das S, Bhunia S, Bal Raju K, et al. Multidrug salt forms of norfloxacin with non-steroidal anti-inflammatory drugs: Solubility and membrane permeability studies. CrystEngComm. 2018;**20**(41):6420-6429. DOI: 10.1039/ c8ce00900g

Section 2
